Inhibrx Biosciences Cash on Hand 1970-1969 | INBX

Inhibrx Biosciences cash on hand from 1970 to 1969. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Inhibrx Biosciences Annual Cash on Hand
(Millions of US $)
Inhibrx Biosciences Quarterly Cash on Hand
(Millions of US $)
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.244B $0.000B
Inhibrx Inc. is a clinical-stage biopharmaceutical company. It focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx Inc. is based in SAN DIEGO.
Stock Name Country Market Cap PE Ratio
Ocwen Financial (ONIT) United States $0.180B 3.16
Capricorn Energy (CRNCD) United Kingdom $0.135B 0.00